Hans F. A. Vasen - Concepedia

Author

Hans F. A. Vasen

Also Known As

Albert de la Chapelle, C.E. van Roozendaal, Christi J van Asperen, E. B. Gómez-Garcia, H F A VASEN, H F A Vasen, H F Vasen, H VASEN, H Vasen, H. F. A. VASEN

608

Publications

49.3K

Citations

110

H-Index

138

Concepts

All Affiliations

Leiden University Medical Center Netherlands Consortium for Healthy Ageing Leiden University Radboud University Nijmegen University Medical Center Groningen

About

Hans F. A. Vasen is an author at Leiden University Medical Center specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	68	135	21.2K
2	Public Health	24	36	3.4K
3	Natural Sciences	5	5	770
4	Health Sciences	3	3	63
5	Engineering	2	2	70

Hans F. A. Vasen

297

Publications

40.1K

Citations

H-Index

Page 1

	Year	Citations
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability Asad Umar, C. Richard Boland, Jonathan P. Terdiman, JNCI Journal of the National Cancer Institute Lynch SyndromeCancer PathologyMedicineGeneticsMicrosatellite Instability	2004	3.2K
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Deborah Ford, Douglas F. Easton, Michael R. Stratton, The American Journal of Human Genetics	1998	3K
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆ Hans F. A. Vasen, Peter H. Watson, Jukka‐Pekka Mecklin, Gastroenterology Lynch SyndromeOncologyCancer PathologyGastrointestinal OncologyMedicine	1999	2.5K
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) Hans F. A. Vasen, Jukka‐Pekka Mecklin, P. Meera Khan, Diseases of the Colon & Rectum Cancer PathologyGeneticsCancer ManagementGenetic EpidemiologyNational Cancer Society	1991	2.1K
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial John Burn, Anne‐Marie Gerdes, Finlay Macrae, The Lancet Long-term EffectOncologyCancer EpidemiologyCancer RiskMedicine	2011	940
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Hans F. A. Vasen, Ignacio Blanco, Katja Aktan–Collan, Gut	2013	722
Guidelines for the clinical management of familial adenomatous polyposis (FAP) Hans F. A. Vasen, Gabriela Möslein, Ángel Alonso, Gut Gastrointestinal OncologyFamilial Adenomatous PolyposisGeneticsMedicineGastroenterology	2008	691
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database Mev Dominguez–Valentin, Julian R. Sampson, Toni T. Seppälä, Genetics in Medicine	2019	615
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium Michael Goggins, Kasper A. Overbeek, Randall E. Brand, Gut	2019	595
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome Patrice Watson, Hans F. A. Vasen, Jukka‐Pekka Mecklin, International Journal of Cancer	2008	584

Page 1